Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $913.85 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $217.94 | 10 | $0 (2024) |
| Amgen Inc. | $170.64 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $114.55 | 6 | $0 (2024) |
| Baxter Healthcare | $97.06 | 2 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $92.84 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $65.82 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $61.80 | 3 | $0 (2018) |
| Keryx Biopharmaceuticals, Inc. | $33.18 | 2 | $0 (2018) |
| Ardelyx, Inc. | $23.67 | 1 | $0 (2024) |
| Novo Nordisk Inc | $19.62 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.08 | 8 | Fresenius USA Marketing, Inc. ($83.83) |
| 2023 | $44.07 | 2 | AstraZeneca Pharmaceuticals LP ($44.07) |
| 2022 | $72.55 | 1 | Baxter Healthcare ($72.55) |
| 2019 | $95.60 | 6 | AKEBIA THERAPEUTICS INC ($52.41) |
| 2018 | $228.44 | 12 | Amgen Inc. ($60.75) |
| 2017 | $216.11 | 9 | Amgen Inc. ($109.89) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $31.77 | General |
| 09/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.05 | General |
| 07/29/2024 | Fresenius USA Marketing, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $83.83 | General |
| Category: Nephrology | ||||||
| 07/19/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Nephrology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Nephrology | ||||||
| 03/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2022 | Baxter Healthcare | Renal - PD (Device) | Food and Beverage | In-kind items and services | $72.55 | General |
| Category: Renal | ||||||
| 08/13/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: NEPHROLOGY | ||||||
| 08/13/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: NEPHROLOGY | ||||||
| 04/23/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/22/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: NEPHROLOGY | ||||||
| 01/08/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/18/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: NEPHROLOGY | ||||||
| 08/28/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Nephrology | ||||||
| 07/25/2018 | Baxter Healthcare | Renal - Amia (Device) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Renal | ||||||
| 07/10/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: NEPHROLOGY | ||||||
| 06/26/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Nephrology | ||||||
| 06/12/2018 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Nephrology | ||||||
| 05/04/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Nephrology | ||||||
| 05/01/2018 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 158 | 596 | $299,500 | $135,122 |
| 2022 | 10 | 662 | 2,184 | $676,424 | $272,529 |
| 2021 | 13 | 1,250 | 3,827 | $1.0M | $403,397 |
| 2020 | 13 | 1,650 | 5,110 | $1.3M | $435,059 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 62 | 385 | $211,750 | $100,131 | 47.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 58 | 132 | $66,000 | $28,534 | 43.2% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 14 | 33 | $14,850 | $4,880 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 46 | $6,900 | $1,577 | 22.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 87 | 544 | $256,000 | $141,455 | 55.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 76 | 228 | $94,650 | $49,905 | 52.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 172 | 680 | $153,776 | $36,069 | 23.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 128 | 420 | $93,536 | $23,001 | 24.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 29 | 49 | $18,900 | $7,417 | 39.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 73 | 74 | $31,210 | $7,364 | 23.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 39 | 100 | $11,784 | $2,888 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 57 | $6,592 | $2,040 | 30.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 19 | $5,984 | $1,455 | 24.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $3,992 | $935.80 | 23.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 92 | 620 | $248,000 | $167,117 | 67.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 391 | 1,482 | $323,669 | $78,787 | 24.3% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 108 | 320 | $112,000 | $71,968 | 64.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 228 | 729 | $160,088 | $39,767 | 24.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 155 | 159 | $66,780 | $15,717 | 23.5% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 33 | 72 | $21,600 | $11,029 | 51.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 94 | 235 | $27,692 | $6,721 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 69 | $8,280 | $4,054 | 49.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 55 | $17,322 | $4,003 | 23.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 27 | 28 | $8,598 | $2,119 | 24.6% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 11 | 22 | $5,708 | $1,364 | 23.9% |
About Dr. Gary Davis, MD
Dr. Gary Davis, MD is a Nephrology healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912065251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Davis, MD has received a total of $913.85 in payments from pharmaceutical and medical device companies, with $257.08 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($913.85).
As a Medicare-enrolled provider, Davis has provided services to 3,720 Medicare beneficiaries, totaling 11,717 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Jackson, MS
- Active Since 12/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1912065251
Products in Payments
- Parsabiv (Biological) $170.64
- Velphoro (Drug) $103.05
- NXSTAGE SYSTEM ONE (Device) $83.83
- Auryxia (Drug) $73.61
- Renal - PD (Device) $72.55
- FARXIGA (Drug) $64.62
- AURYXIA (Drug) $52.41
- LOKELMA (Drug) $49.93
- JYNARQUE (Drug) $40.62
- Dialyzers (Device) $31.06
- Renal - Amia (Device) $24.51
- IBSRELA (Drug) $23.67
- SAMSCA (Drug) $21.18
- Victoza (Drug) $19.62
- Rituxan (Biological) $16.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Jackson
Dr. Ramzi Vareldzis, Md, MD
Nephrology — Payments: $3,922
Murphy Martin, Md, MD
Nephrology — Payments: $3,872
Dr. Victor Nwazue, M.d, M.D
Nephrology — Payments: $2,921
Dr. Carla Monico, M.d, M.D
Nephrology — Payments: $2,871
Catherine Wells, Np, NP
Nephrology — Payments: $2,707
Pradeep Kumar Vaitla, Md, MD
Nephrology — Payments: $2,404